HSIC

Business Context and Reporting Period

Company: Henry Schein, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 28, 2009
Business Overview: Henry Schein is a leading distributor of healthcare products and services to office-based practitioners, including dental, medical, and animal health clinics. The company operates through two reportable segments: Healthcare Distribution and Technology.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 2.2% ($33.2 million) year-over-year. This was driven by a 7.7% negative impact from foreign currency exchange, partially offset by 5.5% local currency growth (0.5% organic, 5.0% from acquisitions).
• Profitability Improvement: Despite lower sales, Operating Income increased 6.6% to $90.9 million, and Net Income increased 6.6% to $54.9 million. This was primarily due to a 5.3% reduction in Selling, General, and Administrative (SG&A) expenses ($19.3 million decrease) driven by cost-cutting initiatives and favorable foreign exchange effects.
• Cash Flow Deterioration: Operating cash flow swung from a positive $13.4 million in Q1 2008 to a negative $27.1 million in Q1 2009. Management attributed this $40.5 million decline primarily to the timing of vendor payments occurring early in the quarter, which unfavorably affected cash flow by approximately $40.0 million to $50.0 million.
• Restructuring Costs: The company recorded $4.0 million in restructuring costs in Q1 2009 related to a plan announced in November 2008 to eliminate approximately 400 positions and close facilities. No restructuring costs were recorded in the prior year period.

Guidance, Outlook, and Risks

• Outlook: Management expects demand for products and services to grow at slower rates due to the current economic environment. They anticipate future increases in working capital requirements.
• Capital Expenditures: The company expects to invest approximately $27.0 million to $37.0 million in capital projects for the remainder of the fiscal year to modernize facilities and computer systems.
• Liquidity and Debt: The company maintains a $400.0 million revolving credit facility with no borrowings outstanding as of March 28, 2009. It holds $57.7 million available for future common stock repurchases, though no repurchases were made in the quarter.
• Investment Risks:
  • Auction-Rate Securities (ARS): Approximately $25.9 million is invested in ARS. Due to failed auctions since February 2008, these assets are illiquid and cannot be liquidated in the near term. A temporary impairment of $0.4 million was recorded.
  • Money Market Fund: Approximately $3.6 million is invested in the Reserve Primary Fund, which holds Lehman Brothers commercial paper. The fund's net asset value dropped below $1.00 following Lehman's bankruptcy, and the fund is in liquidation.
• Internal Controls: The company noted a material change in internal controls due to ongoing acquisition integrations and the outsourcing of accounting records for its Long Term Incentive Program.

Investor Verification Checklist

• Working Capital Timing: Verify if the negative operating cash flow is a one-time timing issue regarding vendor payments or indicative of a broader trend in receivables/payables management.
• ARS Liquidity: Monitor the status of the $25.9 million in auction-rate securities and the potential for further impairments or inability to access these funds.
• Restructuring Savings: Track the realization of the expected $24.0 million to $27.0 million in annual pretax cost savings from the restructuring plan.
• Foreign Exchange Impact: Assess the sensitivity of future earnings to foreign currency fluctuations, which significantly impacted sales in the current quarter.
• Convertible Debt: Review the terms of the $240.0 million convertible debt (maturing 2034) and the impact of the recent accounting standard change (FSP APB 14-1) on interest expense and equity.